Trial of Aerobic Exercise in Patients Undergoing Outpatient Hemodialysis

Sponsor
University of Manitoba (Other)
Overall Status
Completed
CT.gov ID
NCT00492362
Collaborator
(none)
60
4
2
10
15
1.5

Study Details

Study Description

Brief Summary

Randomized controlled trial comparing effects of ergometer exercise during hemodialysis to effects of pedometer use outside of hemodialysis on exercise capacity, functional status, quality of life and adequacy of hemodialysis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ergometer exercise during hemodialysis
  • Behavioral: pedometer activity outside of hemodialysis
N/A

Detailed Description

Study Design:

Prospective, randomized, controlled trial of chronic hemodialysis outpatients within the Manitoba Renal Program.

Potential patients include any individual receiving chronic outpatient hemodialysis in Winnipeg (Seven Oaks, Sherbrook, Central and St. Boniface dialysis units) and the Brandon hemodialysis unit.

Exercise Interventions:
Patients will be block randomized to one of the following 2 interventions:

Group A: Cycling on an ergometer GOAL 60 minutes 3 times per week on hemodialysis for 24 weeks A cycling ergometer will be placed on the floor in front of the patient's dialysis chair or at the foot of the bed (if there are only beds available in that unit). The patient will be allowed to exercise anytime during the first half of each dialysis treatment. Goal frequency will be 3 times per week during their usual scheduled hemodialysis treatments.

Group B: Pedometers This group will each receive a pedometer (StepsCount®) at the onset of the study following exercise testing. They will be educated regarding the technical use of the pedometer and will receive the handout entitled "Pedometer Information Sheet: Get Physically Active One Step at a Time!" They will also receive verbal education regarding use of the pedometer and goal activity levels from the exercise study supervisor.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Randomized Controlled Trial of Aerobic Exercise in Patients With End Stage Renal Disease During Outpatient Hemodialysis
Study Start Date :
Jul 1, 2007
Actual Primary Completion Date :
May 1, 2008
Actual Study Completion Date :
May 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: A

Ergometer during hemodialysis

Behavioral: ergometer exercise during hemodialysis

Active Comparator: B

Pedometer use outside of hemodialysis

Behavioral: pedometer activity outside of hemodialysis

Outcome Measures

Primary Outcome Measures

  1. Aerobic exercise capacity as measured by VO2 peak [3 and 6 months]

  2. physical function as measured by sit to stand to sit; sit and reach and 6 minute walk test [3 and 6 months]

Secondary Outcome Measures

  1. quality of life measured by SF36 [3 and 6 months]

  2. dialysis adequacy as measured by ktV [3 and 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All adult (>18 years old) patients

  • Treated with hemodialysis for > 3 months

  • Hemoglobin > 100 g/L over the previous 2 months

  • Kt/V > 1.2 for last month and no history of shortened dialysis due to hemodialysis access issues or frequent alarming during dialysis due to poor access will be eligible for the study.

  • Study patients must also be likely able to complete 12 consecutive weeks of exercise (i.e. no travel, change of modality, elective surgery planned) and must be able to comprehend instructions in English.

Exclusion Criteria:
  • Acute medical illness in last month

  • Unstable hemodialysis with frequent hypotension over the past month

  • Active cardiovascular disease (stroke or acute coronary syndrome, unstable angina) in last 3 months

  • Lower extremity amputation with no prosthesis (inability to pedal a bike)

  • Spine compression fractures

  • Severe musculoskeletal pain at rest or with minimal activity

  • Inability to sit, stand or walk unassisted (walking devices such as cane will be allowed)

  • Shortness of breath at rest or with activities of daily living (NYHA Class IV)

  • Labile glycemic control with hypoglycaemic episodes > 1x/week.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sherbrook Dialysis Unit Winnipeg Manitoba Canada R3A1M2
2 Central Dialysis Unit, Health Sciences Centre Winnipeg Manitoba Canada R3A1R9
3 Seven Oaks General Hospital Winnipeg Manitoba Canada
4 St. Boniface General Hospital Winnipeg Manitoba Canada

Sponsors and Collaborators

  • University of Manitoba

Investigators

  • Principal Investigator: Clara J Bohm, MD, University of Manitoba; Manitoba Renal Program

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00492362
Other Study ID Numbers:
  • B2007:067
First Posted:
Jun 27, 2007
Last Update Posted:
Jun 4, 2008
Last Verified:
Jun 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 4, 2008